Bullous mastocytosis: Report of a patient and a brief review of the literature

American Journal of Dermatopathology

Volumn 30, Issue 5, 2008, Pages 455-457

  Avshalumov, Kristina ^a   Pichardo, Rita ^b   Jorizzo, Joseph L ^b   Sangueza, Omar P ^b   Goldenberg, Gary ^c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Bullous; C Kit; Mastocytosis; Review

Indexed keywords

FLUOCINONIDE; STEM CELL FACTOR; SULFADIAZINE SILVER; TACROLIMUS; GLUCOCORTICOID; STEM CELL FACTOR RECEPTOR; TOPICAL ANTIINFECTIVE AGENT;

ARM; ARTICLE; BEDTIME DOSAGE; BLOOD CELL COUNT; CASE REPORT; CELL NUCLEUS; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CREAM; DERMIS; DIFFERENTIAL DIAGNOSIS; EPIDERMIS; EROSION; FOLLOW UP; HISTOLOGY; HUMAN; INFANT; LABORATORY; MALE; MAST CELL; MASTOCYTOSIS; MORNING DOSAGE; OINTMENT; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RASH; SEPSIS; SKIN DEFECT; TRUNK; UNIVERSITY HOSPITAL; METABOLISM; PATHOLOGY; REVIEW; URTICARIA PIGMENTOSA;

ANTI-INFECTIVE AGENTS, LOCAL; FLUOCINONIDE; GLUCOCORTICOIDS; HUMANS; INFANT; MALE; MAST CELLS; MASTOCYTOSIS, CUTANEOUS; PROTO-ONCOGENE PROTEINS C-KIT; SILVER SULFADIAZINE;

EID: 58149312891     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3181783354     Document Type: Article

References (23)

1. Tharp M. Mastocytosis. In: Bolognia JL, Jorizzo J, Rapini R, eds. Dermatology. Philadelphia: Elsevier; 2003:1899-1906.
2. Has C, Misery L, David L, et al. Recurring staphylococcal scalded skin syndrome-like bullous mastocytosis: the utility of cytodiagnosis and the rapid regression with steroids. Pediatr Dermatol. 2002;19:220.
3. Soter N. The skin and mastocytosis. J Invest Dermatol. 1991;96:32S-38S.
4. Hartmann K, Henz BM. Mastocytosis: recent advances in defining the disease. Br J Dermatol. 2001;144:682.
5. Weedon D. Skin Pathology. Philadelphia: Elsevier Science; 2002:1064-1067.
6. Husak R, Blume-Peytavi U, Pfrommer C, et al. Nodular and bullous cutaneous mastocytosis of the xanthelasmoid type: case report. Br J Dermatol. 2001;144:355-358.
7. Murphy M, Walsh D, Drumm B, et al. Bullous mastocytosis: a fatal outcome. Pediatr Dermatol. 1999;16:452-455.
8. Fowler JF, Parsley WM, Cotter PG. Familial urticaria pigmentosa. Arch Dermatol. 1986;122:80-81.
9. Orkin M, Gord RA, Clawson CC, et al. Bullous mastocytosis. Arch Dermatol. 1970;101:547-564.
10. Patnaik M, Rindos M, Kouides P, et al. Systemic mastocytosis: a concise clinical and laboratory review. Arch Pathol Lab Med. 2007;131:784-791.
11. Walker T, von Komorowski G, Scheurlen W, et al. Neonatal mastocytosis with pachydermic bullous skin without c-Kit 816 mutation. Dermatology. 2006;212:70-72.
12. Waxtein LM, Vega-Memije ME, Cortes-Franco R, et al. Diffuse cutaneous mastocytosis with bone marrow infiltration in a child: a case report. Pediatr Dermatol. 2000;17:198-201.
13. Brunning RD, McKenna RW, Rosai J, et al. Systemic mastocytosis: extracutaneous manifestations. Am J Surg Pathol. 1983;7:425-438.
14. Horny HP, Parwaresch MR, Lennert K. Bone marrow findings in systemic mastocytosis. Hum Pathol. 1985;16:808-814.
15. Stevens EC, Rosenthal NS. Bone marrow mast cell morphologic features and hematopoietic dyspoiesis in systemic mast cell disease. Am J Clin Pathol. 2001;116:177-182.
16. Tay Y, Kwok Y, Lee Y. Generalized bullous eruption in an infant. Pediatr Dermatol. 2005;22:79-81.
17. Kahn A, Blum D. Possible role of phenothiazines in sudden infant death. Lancet. 1979;2:364-365.
18. Welch EA, Alper JC, Bogaars H, et al. Treatment of bullous mastocytosis with disodium cromoglycate. J Am Acad Dermatol. 1983;9:349-353.
19. Czarnetzki BM. A double-blind cross-over study of the effect of ketotifen in urticaria pigmentosa. Dermatologica. 1983;166:44-47.
20. Guzzo C, Lavker R, Roberts LJ, et al. Urticaria pigmentosa. Systemic evaluation, and successful treatment with topical steroids. Arch Dermatol. 1991;127:191-196.
21. Kettelhut BV, Metcalfe DD. Pediatric mastocytosis. Ann Allergy. 1994;73: 197-206.
22. Pottier P, Planchon B, Grossi O. Complete remission with imatinib mesylate (Gleevec) of an idiopathic hypereosinophilic syndrome associated with a cutaneous mastocytosis after failure of interferon-alpha. Rev Med Intern. 2003;24:542-546.
23. Roberts LJ II, Sweetman BJ, Lewis RA, et al. Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med. 1980;303:1400-1404.